The effects of genistein on the synthesis and distribution of glycosaminoglycans/proteoglycans by two osteosarcoma cell lines depends on tyrosine kinase and the estrogen receptor density

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 459-464

  Nikitovic, Dragana ^a   Tsatsakis, Aristidis M ^a   Karamanos, Nikos K ^b   Tzanakakis, George N ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Genistein; Glycosaminoglycan; MG 63 cells; Osteosarcoma; Proteoglycan; SAOS 2 cells

Indexed keywords

ESTROGEN RECEPTOR; GALACTOSAMINOGLYCAN; GENISTEIN; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HYALURONIC ACID; PROTEIN TYROSINE KINASE; PROTEOGLYCAN;

ARTICLE; CELL STRAIN; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME MECHANISM; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOGLYCAN SYNTHESIS; RECEPTOR DENSITY;

BONE NEOPLASMS; CELL MEMBRANE; GENISTEIN; GLYCOSAMINOGLYCANS; HUMANS; OSTEOSARCOMA; PROTEIN-TYROSINE KINASES; PROTEOGLYCANS; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED;

EID: 0037233849     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bentzen SM: Prognostic factor studies in oncology: Osteosarcoma as a clinical example. Int J Radiation Oncology Biol Phys 49: 513-518, 2001.
2. Duffaud F, Digue L, Baciuchka-Palmaro M et al.: Osteosarcomas of flat bones in adolescents and adults. Cancer 88: 324-332, 2000.
3. Lee YH, Tokunaga T, Oshika Y, Suto R et al.: Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 35: 1089-1093, 1999.
4. Yudoi K, Matsui H, Kanamori M, Ohmori K, Yasuda Y and Tsuji H: Characteristics of high and low laminin-adherent Dunn osteosarcoma cells secreted by adhesiveness to laminin. Correlation between invasiveness through the extracellular matrix and pulmonary metastatic potential. Tumor Biol 17: 332-40, 1996.
5. Pogany G, Timar F, Olah J, Harisi R et al.: Role of the basement membrane in tumor cell dormancy and cytotoxic resistence. Oncology 60: 274-81, 2001.
6. Aumailley M and Gayraud B: Structure and biological activity of the extracellular matrix. J Mol Med 253-265, 1998.
7. Kjellen L, and Lindahl U: Proteoglycans: structures and interactions. Annu Rev Biochem 60: 853-856, 1991.
8. David G: Integral mebrane heparan sulfate proteoglycans. FASEB J 7: 1023-1030, 1993.
9. Wight TN, Kinsell MG and Qwarnstroem E: The role of proteoglycans in cell adhesion, migration and proliferation. Curr Opin Cell Biol 4: 793-801, 1992.
10. Iozzo RV: The family of the small leucine rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol 32: 141-174, 1998.
11. Birch MA and Skerry TM: Differential regulation of syndecan expression by osteosarcoma cell lines in response to cytokines but not osteotropic hormones. Bone 24: 571-578, 1999.
12. McQuillan DJ, Findlay DM, Hocking AM, Yanagishita M, Midura RJ and Hascall VC: Proteoglycans synthesized by an osteoblast-like cell line (UMR 106-01). Biochem J 277: 199-206, 1991.
13. Benayahu D, Shur I, Marom R, Meller I and Issakov J: Cellular and molecular properties associated with osteosarcoma cells. J Cellular Biochem 84: 108-114, 2001.
14. Barnes S: Effect of genistein on in vitro and in vivo models of cancer. J Nutr 125: 777S-783S, 1995.
15. Tzanakakis GN, Hjerpe A and Karamanos NK: Proteoglycan synthesis induced by transforming and basic fibroblast growth factors in human malignant mesothelioma is mediated through specific receptors and the tyrosine kinase intracellular pathway. Biochimie 79: 323-332, 1997.
16. Mitropoulou TN, Tzanakakis GN, Nikitovic D, Tsatsakis A and Karamanos NK: In vitro effects of genistein on synthesis and distribution of glycosaminoglycans/proteoglycans by estrogen receptor-positive and -negative human breast cancer epithelial cells. Anticancer Res 22, 2002 in press.
17. Sandy J, Davies M, Prime S and Farndale R: Signal pathways that transduce growth factor-stimulated mitogenesis in bone cells. Bone 23: 17-26, 1998.
18. Wang TTY, Sathyamoorthy and Phang JM: Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17: 271-275, 1996.
19. Peterson G: Evaluation of the biochemical targets of genistein in tumor cells. J Nutr 125(Suppl 3): 698S-708S, 1995.
20. Pagliacci MC, Smachia M, Migliorati G, Grignani F, Riccardi C and Nicoletti I: Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur J Cancer 30: 1675-1682, 1994.
21. Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H and Aoike A: Genistein arrests cell cycle progression in G2-M. Cancer Res 53: 1328-31, 1993.
22. Lepley DM and Pelling JC: Induction of p21/WAF1 and G1 cell-cycle by the chemopreventive agent apigenin. Mol Carcinog 19: 74-82, 1997.
23. Billiau A: Antimicrob Agents Chemother 12: 11-15, 1977.
24. Fogh J and Trempe G: In: Human Tumor Cells In Vitro (Fogh J ed.). New York, Plenum press 1975, pp. 115-159.
25. Karamanos NK: Proteoglycans: biological roles and strategies for isolation and determination of their glycan constituents. In: Proteome and Protein Analysis (Kamp RM, Kyriakidis DA and Choli-Papadopoulou T, eds). Heidelberg, Springer-Verlag Inc. 1999, pp 341-363.
26. Karamanos NK, Axelsson S, Vanky P, Tzanakakis GN and Hjerpe A: Determination of hyaluronan and galactosaminoglycan disaccharides by high performance capillary electrophoresis at the attomole level. Applications to analyses of tissue and cell culture proteoglycans. J Chromatogr A 696: 295-305, 1995.
27. Antonopoulos CA, Borelious E, Hamnstrom B and Scott JE: The precipitation of polyanions by long-chain aliphatic ammonium compounds. Elution in salt solutions of mucopolysaccharide ammonium complexes absorbed on a support. Biochim Biophys Acta 54: 213-226, 1961.
28. Yamagata T, Saito H, Habuchi O and Suziki S: Purification and properties of bacterial chindroitinases and chondrosulfatases. J Biol Chem 243: 1523-1535, 1968.
29. Karamanos NK, Syrokou A, Vanky P, Nurminen M and Hjerpe A: Determination of twenty-four variously sulfated galactosaminoglycans and hyaluronan-derived disaccharides by high performance liquid chromatography. Anal Biochem 221: 189-199, 1994.
30. Hashimoto N, Morikawa K, Kikuchi M, Yoshida K and Tokuyasu K: Purification and properties of a new keratan sulfate degrading enzyme. Seikagaku 60: 935-938, 1988.
31. Karamanos NK, Vanky P, Tzanakakis GN, Tsegenidis T and Hjerpe A: Ion-pair high-performance liquid chromatography for detecting disaccharide composition in heparin and heparan sulfate. J Chromatogr A 765: 169-179, 1997.
32. Syrokou A, Tzanakakis GN, Hjerpe A and Karamanos NK: Cell proliferation and proteoglycan synthesis induced by epidermal, insulin and platelet-derived growth factors in human malignant mesothelioma involve growth factor receptors with tyrosine kinase activity. Biochemie 81: 733-744, 1999.
33. Robinson JA, Waters KM, Turner RT and Spelsberg TC: Direct action of naturally occurring estrogen metabolites on human osteoblastic cells. J Bone Miner Res 15: 499-506, 2000.
34. Kassem M, Harris SA, Spelsberg TC and Riggs BL: Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with a high level of estrogen receptors. J Bone Miner Res 11: 193-199, 1996.
35. Vidal O, Kindblom LG and Ohlsson C: Expression and localization of estrogen receptor-beta in murine and human bone. J Bone Miner Res 14: 923-929, 1999.
36. Dovio A, Sartori ML, Masera RG, Racca S and Angeli A: Inhibitory effect of physiological concentrations of cortizol but not estradiol on interleukin (II)-6 production by human osteoblast-like cell lines with different constitutive IL-6 expression. Cytokine 15: 47-52, 2001.
37. Kuiper GG, Lemmen JG and Carlsson B: Interaction of estrogenic chemicals and phyto-estrogens with estrogen receptor beta. Endocrinology 139: 4252-4263, 1998.